Publiseringer

Tidsskriftspublikasjon

• Coeliac disease in the Trøndelag Health Study (HUNT), Norway, a population-based cohort of coeliac disease patients

  2024:

  Polina Lukina,

  Ina Lervåg Andersen,

  Petter Tinbod Eggen,

  Patricia Gjertrud Mjønes,

  Elin Rønne,

  Nils Bolstad
• Risk of Cancer in Patients With Crohn's Disease 30 Years After Diagnosis (the IBSEN Study)

  2023:

  Benoit Follin-Arbelet,

  Milada Cvancarova Småstuen,

  Øistein Hovde,

  Lars-Petter Jelsness-Jørgensen,

  Bjørn Allan Moum
• Symptoms and symptom clusters in patients newly diagnosed with inflammatory bowel disease: results from the IBSEN III Study

  2023:

  Ingunn Johansen,

  Milada Cvancarova Småstuen,

  Stine Eileen Torp Løkkeberg,

  Vendel Ailin Kristensen,

  Marte Lie Høivik,

  Charlotte Lund
• Incidence of cancer in patients with ulcerative colitis 30 years after diagnosis (the IBSEN study)

  2023:

  Benoit Follin-Arbelet,

  Milada Cvancarova Småstuen,

  Øistein Hovde,

  Lars-Petter Jelsness-Jørgensen,

  Bjørn Allan Moum
• Fatigue in Patients with Newly Diagnosed Inflammatory Bowel Disease: Results from a Prospective Inception Cohort, the IBSEN III Study

  2023:

  Kristina Ingeborg Holten,

  Tomm Bernklev,

  Randi Opheim,

  Ingunn Johansen,

  Bjørn Christian Elias Grova Olsen,

  Charlotte Lund
• Health-related quality of life in patients with newly diagnosed inflammatory bowel disease: an observational prospective cohort study (IBSEN III)

  2023:

  Bjørn Christian Elias Grova Olsen,

  Randi Opheim,

  Marte Lie Høivik,

  Charlotte Lund,

  Tone Bergene Aabrekk,

  Ingunn Johansen
• The Role of Procalcitonin as an Antimicrobial Stewardship Tool in Patients Hospitalized with Seasonal Influenza

  2023:

  Ingrid Christensen,

  Dag Berild,

  Jørgen Bjørnholt,

  Lars-Petter Jelsness-Jørgensen,

  Sara Molvig Debes,

  Jon Birger Haug
• Associations between unit workloads and outcomes of first extubation attempts in extremely premature infants below a gestational age of 26 weeks

  2023:

  Mari Oma Ohnstad,

  Hans Jørgen Stensvold,

  Are Hugo Pripp,

  Christine Raaen Tvedt,

  Lars-Petter Jelsness-Jørgensen,

  Henriette Astrup
• Health-related quality of life in inflammatory bowel disease: a comparison of patients receiving nurse-led versus conventional follow-up care

  2022:

  Line Alvestad,

  Lars-Petter Jelsness-Jørgensen,

  Rasmus Goll,

  Anne Mary Gerard Clancy,

  Thomas Gressnes,

  Per Christian Valle
• Mortality in Patients with Inflammatory Bowel Disease: Results from 30 Years of Follow-up in a Norwegian Inception Cohort (the IBSEN study)

  2022:

  Benoit Follin-Arbelet,

  Milada Cvancarova Småstuen,

  Øistein Hovde,

  Lars-Petter Jelsness-Jørgensen,

  Bjørn Allan Moum
• Predictors of extubation success: a population-based study of neonates below a gestational age of 26 weeks

  2022:

  Mari Oma Ohnstad,

  Hans Jørgen Stensvold,

  Are Hugo Pripp,

  Christine Raaen Tvedt,

  Lars-Petter Jelsness-Jørgensen,

  Henriette Astrup
• Antitumour necrosis factor alpha treatment in Crohn's disease: long-term efficacy, side effects and need for surgery

  2022:

  Frode Lerang,

  Rene Holst,

  Magne Henriksen,

  Henrik Wåhlberg,

  Lars-Petter Jelsness-Jørgensen
• Integrating simulation training during clinical practice in nursing homes: An experimental study of nursing students´ knowledge acquisition, self-efficacy and learning needs

  2022:

  Camilla Olaussen,

  Simen Alexander Steindal,

  Lars-Petter Jelsness-Jørgensen,

  Ingunn Aase,

  Hege Vistven Stenseth,

  Christine Raaen Tvedt
• The multidimensional fatigue inventory (MFI-20): psychometrical testing in a Norwegian sample of inflammatory bowel disease (IBD) patients

  2022:

  Lars-Petter Jelsness-Jørgensen,

  Bjørn Allan Moum,

  Tore Bjørn Grimstad,

  Jørgen Jahnsen,

  Øistein Hovde,

  Svein Oskar Frigstad
• Factors Affecting Antibiotic Prescription among Hospital Physicians in a Low-Antimicrobial-Resistance Country: A Qualitative Study

  2022:

  Ingrid Christensen,

  Jon Birger Haug,

  Dag Berild,

  Jørgen Bjørnholt,

  Brita Skodvin,

  Lars-Petter Jelsness-Jørgensen
• Health-related quality-of-life questionnaires for deep vein thrombosis and pulmonary embolism: A systematic review on questionnaire development and methodology

  2021:

  Elia Asady,

  Waleed Ghanima,

  Lars-Petter Jelsness-Jørgensen,

  Erik Klok,

  Susan R. Kahn,

  Hilde Strømme
• Cross-cultural adaptation and validation of the Norwegian version of the Leicester Cough Questionnaire in chronic obstructive pulmonary disease

  2021:

  Stacey Marie Haukeland-Parker,

  Eivind Hasvik,

  Lars-Petter Jelsness-Jørgensen,

  Surinder S. Birring,

  Hege Hølmo Johannessen
• Supplementing Clinical Practice in Nursing Homes With Simulation Training: A Qualitative Study of Nursing Students’ Experiences

  2020:

  Camilla Olaussen,

  Ingunn Aase,

  Lars-Petter Jelsness-Jørgensen,

  Christine Raaen Tvedt,

  Simen Alexander Steindal
• Psychometric properties of the Norwegian version of the clinical learning environment comparison survey

  2020:

  Camilla Olaussen,

  Lars-Petter Jelsness-Jørgensen,

  Christine Raaen Tvedt,

  Dag Hofoss,

  Ingunn Aase,

  Simen Alexander Steindal
• Hospital physicians' experiences with procalcitonin - implications for antimicrobial stewardship; a qualitative study.

  2020:

  Ingrid Christensen,

  Jon Birger Haug,

  Dag Berild,

  Jørgen Vildershøj Bjørnholt,

  Lars-Petter Jelsness-Jørgensen
• Interventions for fatigue in inflammatory bowel disease

  2020:

  Dawn Farrell,

  Micol Artom,

  Wladyslawa Czuber-Dochan,

  Lars-Petter Jelsness-Jørgensen,

  Christine Norton,

  Eileen Savage
• Fatigue after initiating rivaroxaban for venous thromboembolism

  2020:

  Tina Margrethe Karlsvik,

  Thore Langfeldt Borgenvik,

  Mirjam Aadalen,

  Kristin Kornelia Utne,

  Eli Førsund,

  Camilla Tøvik Jørgensen
• Self-esteem in patients with inflammatory bowel disease

  2020:

  Randi Opheim,

  Bjørn Moum,

  Tore Grimstad,

  Jørgen Jahnsen,

  Ingrid Prytz Berset,

  Øistein Hovde
• Association between vitamin D and fatigue in patients with rheumatoid arthritis: a cross-sectional study

  2020:

  Lars-Petter Jelsness-Jørgensen,

  Lars Grøvle,

  Anne Julsrud Haugen
• Pain Severity and Vitamin D Deficiency in IBD Patients

  2020:

  Svein Oskar Frigstad,

  Marte Lie Høivik,

  Jørgen Jahnsen,

  Milada C Småstuen,

  Tore Grimstad,

  Ingrid Prytz Berset
• Psychometric testing of the Norwegian Diabetes Health Profile (DHP-18) in patients with type 1 diabetes

  2018:

  Lars-Petter Jelsness-Jørgensen,

  Øystein Jensen,

  Charlotte Christine Gibbs,

  Ragnar Bekkhus Moe,

  Dag Hofsø,

  Tomm Bernklev
• Fatigue as an extra-intestinal manifestation of celiac disease: A systematic review

  2018:

  Lars-Petter Jelsness-Jørgensen,

  Tomm Bernklev,

  Knut Erik Aslaksen Lundin
• The impact of post-pulmonary embolism syndrome and its possible determinants

  2018:

  Mazdak Tavoly,

  Hilde Skuterud Wik,

  Per-Anton Sirnes,

  Lars-Petter Jelsness-Jørgensen,

  Josef P. Ghanima,

  Frederikus A. Klok
• Fatigue is not associated with vitamin D deficiency in inflammatory bowel disease patients

  2018:

  Svein Oskar Frigstad,

  Marte Lie Høivik,

  Jørgen Jahnsen,

  Milada Cvancarova Småstuen,

  Tore Grimstad,

  Ingrid Prytz Berset

• Cøliaki og fatigue - en vanlig kombinasjon

  2018:

  Knut Erik Aslaksen Lundin,

  Lars-Petter Jelsness-Jørgensen,

  Tomm Bernklev
• Fatigue in type 1 diabetes, prevalence, predictors and comparison with the background population

  2018:

  Øystein Jensen,

  Tomm Bernklev,

  Charlotte Christine Gibbs,

  Ragnar Bekkhus Moe,

  Dag Hofsø,

  Lars-Petter Jelsness-Jørgensen
• Rivaroxaban versus warfarin for the prevention of post-thrombotic syndrome

  2018:

  Kristin Kornelia Utne,

  Anders Erik A Dahm,

  Hilde Skuterud Wik,

  Lars-Petter Jelsness-Jørgensen,

  Per Morten Sandset,

  Waleed Khalid Ghanima
• Irritable bowel-like symptoms in ulcerative colitis are as common in patients in deep remission as with inflammation; results from a population-based study (the IBSEN study).

  2018:

  Magne Henriksen,

  Marte Lie Høivik,

  Lars-Petter Jelsness-Jørgensen,

  Bjørn Moum
• Late consequences of venous thromboembolism: Measuring quality of life after deep vein thrombosis and pulmonary embolism

  2018:

  Waleed Khalid Ghanima,

  Hilde Skuterud Wik,

  Mazdak Tavoly,

  Tone Rønnaug Enden,

  Lars-Petter Jelsness-Jørgensen
• Vitamin D deficiency is not associated with depression in IBD patients

  2017:

  Svein Oskar Frigstad,

  Marte Lie Høivik,

  Jørgen Jahnsen,

  Sandra Rinne Dahl,

  Milada Cvancarova,

  Tore Grimstad
• Fatigue is not Associated with Vitamin D Deficiency in IBD Patients

  2017:

  Svein Oskar Frigstad,

  Marte Lie Høivik,

  Jørgen Jahnsen,

  Milada C Småstuen,

  Tore Grimstad,

  Ingrid Prytz Berset
• Evaluating patient experiences in decentralised acute care using the Picker Patient Experience Questionnaire; methodological and clinical findings

  2017:

  Ann-Chatrin Linqvist Leonardsen,

  Vigdis Abrahamsen Grøndahl,

  Waleed Khalid Ghanima,

  Espen Storeheier,

  Anders Schönbeck,

  Thor-Asbjørn Løken
• Handovers in primary healthcare in Norway: A qualitative study of general practitioners' collaborative experiences

  2017:

  Ann-Chatrin Linqvist Leonardsen,

  Lilliana Andrea Del Busso,

  Vigdis Abrahamsen Grøndahl,

  Lars-Petter Jelsness-Jørgensen
• Patient experiences and predictors in an acute geriatric ward: a cross-sectional study

  2017:

  Ann-Chatrin Linqvist Leonardsen,

  Lars-Petter Jelsness-Jørgensen
• Erfaringer med mobile intensivsykepleiere (MIS) : mobile intensivsykepleiere rykker ut til sykehusavdelinger der pasienten viser tegn til forverring i helsetilstanden. Når tilkalles de, og hvilke tiltak setter de i verk?

  2017:

  Sasa Katadzic,

  Lars-Petter Jelsness-Jørgensen
• Fatigue in type 1 diabetes: A systematic review of Observational studies

  2017:

  Øystein Jensen,

  Tomm Bernklev,

  Lars-Petter Jelsness-Jørgensen
• Fatigue in a population-based cohort of patients with inflammatory bowel disease 20 years after diagnosis: The IBSEN study

  2017:

  Gert Huppertz-Hauss,

  Marte Høivik,

  Lars-Petter Jelsness-Jørgensen,

  Randi Opheim,

  Magne Henriksen,

  Ole Ingebreth Høie
• Pain may be an important factor to consider in inflammatory bowel disease patients troubled by fatigue

  2017:

  Lars-Petter Jelsness-Jørgensen,

  Svein Oskar Frigstad,

  Bjørn Moum,

  Tore Grimstad,

  Randi Opheim,

  Jørgen Jahnsen
• Vitamin D deficiency in inflammatory bowel disease: Prevalence and predictors in a Norwegian outpatient population

  2017:

  Svein Oskar Frigstad,

  Marte Høivik,

  Jørgen Jahnsen,

  Sandra Rinne Dahl,

  Milada C Småstuen,

  Tore Grimstad
• “It’s a whole human being”: A qualitative study of care experiences among patients treated in de-centralised healthcare services

  2017:

  Ann-Chatrin Linqvist Leonardsen,

  Lilliana Andrea Del Busso,

  Vigdis Abrahamsen Grøndahl,

  Lars-Petter Jelsness-Jørgensen

Konferansebidrag og faglig presentasjon

• Symptoms and symptom clusters in patients newly diagnosed with inflammtory bowel disease – results from the IBSEN III study

  2022:

  Ingunn Johansen,

  Milada Cvancarova Småstuen,

  Stine Eileen Torp Løkkeberg,

  Vendel Ailin Kristensen,

  Marte Lie Høivik,

  Charlotte Lund
• Extubating extremely premature newborns: predictors of success and reasons for failure

  2022:

  Mari Oma Ohnstad,

  Hans Jørgen Stensvold,

  Are Hugo Pripp,

  Christine Raaen Tvedt,

  Lars-Petter Jelsness-Jørgensen,

  Henriette Astrup

• Oral presentation of: Integrating simulation training during clinical practice in nursing homes

  2022:

  Camilla Olaussen,

  Simen Alexander Steindal,

  Lars-Petter Jelsness-Jørgensen,

  Hege Vistven Stenseth,

  Christine Raaen Tvedt

• Oral presentation of Psychometric properties of the Norwegian version of the clinical learning environment comparison survey

  2022:

  Camilla Olaussen,

  Lars-Petter Jelsness-Jørgensen,

  Christine Raaen Tvedt,

  Dag Hofoss,

  Simen Alexander Steindal

• Cøliaki i HUNT. Forekomst, konsekvenser og årsaker

  2022:

  Polina Lukina,

  Ina Lervåg Andersen,

  Rebecka Hjort,

  Petter Tinbod Eggen,

  Marit Næss,

  Patricia Mjønes

• Supplementing clinical practice in nursing homes with simulation training: A qualitative study of nursing students´ experiences

  2021:

  Camilla Olaussen,

  Lars-Petter Jelsness-Jørgensen,

  Christine Raaen Tvedt,

  Ingunn Aase,

  Simen Alexander Steindal

• THE TRANSLATION AND VALIDATION OF THE NORWEGIAN VERSION OF THE LEICESTER COUGH QUESTIONNAIRE

  2020:

  Stacey Marie Haukeland-Parker,

  Eivind Olay Hasvik,

  Lars-Petter Jelsness-Jørgensen,

  Surinder Birring,

  Hege Hølmo Johannessen

• Fatigue og smerte ved IBD, finnes det effektive intervensjoner?

  2019:

  Lars-Petter Jelsness-Jørgensen

• P368 Vedolizumab in inflammatory bowel disease: a retrospective single-centre study

  2019:

  Carl Larsson,

  Magne Henriksen,

  Lars-Petter Jelsness-Jørgensen,

  Andreas Rekvin,

  Frode Lerang

• N04 Interventions for managing fatigue in inflammatory bowel disease: A Cochrane systematic review

  2019:

  Dawn Farrell,

  Eileen Savage,

  Christine Norton,

  Lars-Petter Jelsness-Jørgensen,

  Wladyslawa Czuber-Dochan,

  Micol Artom

• Chronic Fatigue is associated with impared Health-Related Quality of Life in Type 1 Diabetes

  2019:

  Øystein Jensen,

  Tomm Bernklev,

  Charlotte Christine Gibbs,

  Ragnar Bekkhus Moe,

  Dag Hofsø,

  Lars-Petter Jelsness-Jørgensen

• Chronic Fatigue is associated with a significant reduction of Health-Related Quality of life (HRQoL) in type 1 diabetes

  2018:

  Øystein Jensen,

  Tomm Bernklev,

  Charlotte Christine Gibbs,

  Ragnar Bekkhus Moe,

  Dag Hofsø,

  Lars-Petter Jelsness-Jørgensen
• A comparison of Health Related Quality of Life in nurse-led versus conventional Inflammatory Bowel Disease follow-up.

  2018:

  Line Alvestad,

  Lars-Petter Jelsness-Jørgensen,

  Rasmus Goll,

  Anne Clancy,

  Per Christian Valle,

  Ann Ragnhild Broderstad
• Chronic fatigue in patients with inflammatory bowel disease is associated with lower health–related quality of life, low self-esteem, increased anxiety and depression

  2018:

  Randi Opheim,

  Tomm Bernklev,

  Jørgen Jahnsen,

  Tore Grimstad,

  Øistein Hovde,

  Ingrid Prytz Berset

• Chronic fatigue is more prevalent in patients with type 1 diabetes than in the background populasjon: a cross-sectional study

  2017:

  Øystein Jensen,

  Tomm Bernklev,

  Charlotte Gibbs,

  Ragnar Bekkhus Moe,

  Dag Hofsø,

  Lars-Petter Jelsness-Jørgensen

• Fatigue er ikke assosiert med vitamin D mangel hos IBD pasienter

  2017:

  Svein Oskar Frigstad,

  Marte Lie Høivik,

  Milada C Småstuen,

  Jørgen Jahnsen,

  Sandra Rinne Dahl,

  Ingrid Prytz Berset

• Symptomer på irritabel tarmsyndrom (IBS)forekommer hyppig ved ulcerøs kolitt (UC) uavhengig av hvordan remisjon defineres. Resultater fra 20 års oppfølging i IBSEN studien

  2017:

  Magne Henriksen,

  Lars-Petter Jelsness-Jørgensen,

  Marte Lie Høivik,

  Bjørn Moum

• Vitamin D deficiency is not associated with chronic fatigue in inflammatory bowel disease

  2017:

  Svein Oskar Frigstad,

  Tomm Bernklev,

  Sandra Rinne Dahl,

  Øistein Hovde,

  Jørgen Jahnsen,

  Tore Grimstad

• Level of Fatigue after Initiation of Rivaroxaban for Treatment of Venous Thromboembolism

  2017:

  Tina Karlsvik,

  Kristin Kornelia Utne,

  Waleed Khalid Ghanima,

  Lars-Petter Jelsness-Jørgensen

• Rivaroxaban Reduces the Rate of Post-Thrombotic Syndrome After DVT - a Cross-Sectional Study Comparing Rivaroxaban to Warfarin

  2017:

  Kristin Kornelia Utne,

  Hilde Skuterud Wik,

  Lars-Petter Jelsness-Jørgensen,

  Per Morten Sandset,

  Anders Erik A Dahm,

  Mazdak Tavoly

• Adherence - et klinisk problem?

  2017:

  Lars-Petter Jelsness-Jørgensen

• Vitamin D deficiency is not associated with depression in IBD patients

  2017:

  Svein Oskar Frigstad,

  Marte Lie Høivik,

  Bjørn Moum,

  Sandra Rinne Dahl,

  Jørgen Jahnsen,

  Milada Cvancarova Småstuen

• Long-term efficacy of infliximab in patients with ulcerative colitis - an observational study from a single center in Norway

  2017:

  Frode Lerang,

  Magne Henriksen,

  Lars-Petter Jelsness-Jørgensen

Bok eller del av bok/rapport

• Nursing research

  2019:

  Lars-Petter Jelsness-Jørgensen

Diverse

• Skreddersydde tiltak gir bedre antibiotikastyring i norske sykehus

  2022:

  Dag Berild,

  Lars-Petter Jelsness-Jørgensen,

  Jørgen Bjørnholt,

  Jon Birger Haug
• Særnorske universitetsregler må fjernes

  2021:

  Laila Susanne Vars,

  Steinar Kristoffersen,

  Johann Roppen,

  Arne H. Krumsvik,

  Lars-Petter Jelsness-Jørgensen
• «2021 er året da vi vet å verd­sette det 2020 ikke ga oss» : toppene i kunnskapsnorge hilser det nye året med ønske om hedonistiske kjempefester, liv og energi på campus og en porsjon optimisme - etter hvert

  2020:

  Johann Roppen,

  Guro Elisabeth Lind,

  Elisabeth Maråk Støle,

  Henrik Asheim,

  Nina Skarpenes,

  Henrik Urdal

• Kunne studiebarometeret hatt en enda større betydning bare ved enkle justeringer?

  2020:

  Lars-Petter Jelsness-Jørgensen

• 6 av 10 lærer mindre med digital undervisning

  2020:

  Njord Vegard Svendsen,

  Lars-Petter Jelsness-Jørgensen

• Uklare og forvirrende krav til undervisning foreslås endret

  2020:

  Hege Larsen,

  Lars-Petter Jelsness-Jørgensen

• Flere høgskoler og universiteter anbefaler og krever bruk av munnbind

  2020:

  Ragnhild Vartdal,

  Lars-Petter Jelsness-Jørgensen

• «Jeg leier ikke ut til afrikanske gutter» fekk Amanuel (19) til svar frå hybel­utleigar

  2020:

  Ragnhild Vartdal,

  Lars-Petter Jelsness-Jørgensen

• Blir stor omorganisering ved Høgskolen i Østfold

  2020:

  Amanda Schei,

  Lars-Petter Jelsness-Jørgensen

• Østfold og Sørøst-Norge jubler for resultatuttelling

  2020:

  Eva Tønnesen,

  Lars-Petter Jelsness-Jørgensen

• Nifu-rapport: Det må ryddes opp mellom direktoratene

  2020:

  Eva Tønnesen,

  Lars-Petter Jelsness-Jørgensen

• Norge trenger flere grunnskolelærere som er faglig sterke

  2020:

  Anne Borg,

  Johann Roppen,

  Kathrine Skretting,

  Lars-Petter Jelsness-Jørgensen,

  Berit Rokne,

  Hanne Elenora Solheim Hansen

• Kritikere krever endringer i Studiebarometeret

  2020:

  Hege Larsen,

  Lars-Petter Jelsness-Jørgensen

• Vektla behovet for å ta vare på studentene

  2020:

  Eva Tønnesen,

  Lars-Petter Jelsness-Jørgensen

• Helsepersonell ved universiteter og høgskoler er fortsatt klare til innsats

  2020:

  Eva Tønnesen,

  Lars-Petter Jelsness-Jørgensen

• Rektor om ­departementets korona-håndtering: «Fullstendig uforståelig»

  2020:

  Torkjell Trædal,

  Lars-Petter Jelsness-Jørgensen

• Nå må vi snakke sammen om korona

  2020:

  Lars-Petter Jelsness-Jørgensen

• Det er på høy tid med egen forskerutdanning i Østfold

  2020:

  Lars-Petter Jelsness-Jørgensen

• Slik har du aldri sett høyskolerektoren før – nå skal denne VR-teknologien hjelpe barn med autisme

  2020:

  Lars-Petter Jelsness-Jørgensen,

  Anders Dechsling,

  Anders Nordahl-Hansen

• Som rektor kan jeg ikke spille russisk rulett med kvalitet, Bruun-Gundersen

  2019:

  Lars-Petter Jelsness-Jørgensen

• Verdensdagen for psykisk helse: – Vi står sammen om de gode tiltakene for å gjøre studietilværelsen ved HiØ best mulig

  2019:

  Preben Reinaas Rotlid,

  Lars-Petter Jelsness-Jørgensen

• Volda: splitta om aleinegang

  2019:

  Johann Roppen,

  Tor Johan Ekeland,

  Steinar Kristoffersen,

  Johanne Landsverk,

  Lars-Petter Jelsness-Jørgensen
• Skal Høgskulen i Volda fortsatt stå aleine? : styremedlemmer er ueinige med rektor

  2019:

  Johann Roppen,

  Tor-Johan Ekeland,

  Steinar Kristoffersen,

  Lars-Petter Jelsness-Jørgensen,

  Johanne Landsverk
• Disse tre lever fortsatt singellivet

  2019:

  Johann Roppen,

  Steinar Kristoffersen,

  Lars-Petter Jelsness-Jørgensen,

  Tove Lie

• Sterk konkurranse om studieplassene på HiØ

  2018:

  Øyvind Kvitnes,

  Øyvind Kvitnes,

  Lars-Petter Jelsness-Jørgensen

• Høgskolen gir næring til samfunnet

  2018:

  Lars-Petter Jelsness-Jørgensen

• Juks og fanteri i vitenskapelig forskning

  2018:

  Lars-Petter Jelsness-Jørgensen
• Pasientene kjenner best egen helse

  2018:

  Tone Rønnaug Enden,

  Tomm Bernklev,

  Lars-Petter Jelsness-Jørgensen,

  Cecilie Delphin Amdal

• Høgskolen erkjenner: – Forskningsjuks-saken har vært en kraftig lærepenge!

  2017:

  Joachim Constantin Høyer,

  Lars-Petter Jelsness-Jørgensen

• AIDS-dagen 1. desember: Fortsatt viktig å bekjempe stigmatisering

  2017:

  Lars-Petter Jelsness-Jørgensen

• Kommunikasjon og samhandling i helsetjenesten: Hva er de kritiske suksessfaktorer for pasienter med kronisk sykdom?

  2017:

  Lars-Petter Jelsness-Jørgensen